Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Level 6, 18 Innovation Walk, Clayton, VIC, Australia.
Melbourne School of Psychological Sciences, University of Melbourne, Parkville, Victoria, Australia.
J Affect Disord. 2022 Jan 1;296:559-566. doi: 10.1016/j.jad.2021.10.007. Epub 2021 Oct 12.
In older adults, depressive and anxiety symptoms are associated with dementia risk, and represent a manifestation of the dementia prodrome. Understanding how these symptoms are related to cognition in midlife may inform risk models of dementia.
This study examined the relationship between depressive and anxiety symptoms, and cognition, in a sample (n= 2,657) of participants enrolled in the Healthy Brain Project. Depressive and Anxiety symptoms were assessed using the Depression Anxiety and Stress Scale, Hospital Anxiety and Depression Scale, and centre for Epidemiological Studies Depression Scale. Objective cognition was assessed using the Cogstate Brief Battery and subjective cognition assessed using the Alzheimer's disease Cooperative Study Cognitive Function Instrument.
Somatic- and panic-related anxiety symptoms were associated significantly with poorer attention; while tension- and panic-related anxiety were associated significantly with poorer memory. Having clinically meaningful anxiety or depressive symptoms was associated with increased subjective cognitive concerns (d=-0.37). This was further increased for those with clinically meaningful anxiety and depressive symptoms (d = -1.07).
This study reports cross-sectional data, and uses a sample enriched with individuals with a family history of dementia who are therefore at a higher risk of developing dementia compared to the general population. Additionally, biological markers such as cortisol, Aβ, and tau were unavailable.
The results support the hypothesis that depressive and anxiety symptoms may increase risk of cognitive decline. Further, they suggest that using depression and anxiety as clinical markers may be helpful in identifying the earliest signs of cognitive decline.
在老年人中,抑郁和焦虑症状与痴呆风险相关,并且是痴呆前体的表现。了解这些症状与中年认知的关系可能会为痴呆风险模型提供信息。
本研究在参加健康大脑计划的参与者样本(n=2657)中,检查了抑郁和焦虑症状与认知之间的关系。使用抑郁焦虑和压力量表、医院焦虑和抑郁量表以及流行病学研究抑郁量表评估抑郁和焦虑症状。使用 Cogstate 简要电池评估客观认知,使用阿尔茨海默病合作研究认知功能仪器评估主观认知。
躯体相关和惊恐相关的焦虑症状与注意力较差显著相关;而紧张和惊恐相关的焦虑与记忆较差显著相关。有临床意义的焦虑或抑郁症状与增加的主观认知担忧相关(d=-0.37)。对于有临床意义的焦虑和抑郁症状的患者,这种相关性进一步增加(d=-1.07)。
本研究报告的是横断面数据,并且使用了一个富含有痴呆家族史的个体的样本,这些个体与一般人群相比,患痴呆的风险更高。此外,无法获得皮质醇、Aβ 和 tau 等生物标志物。
结果支持这样一种假设,即抑郁和焦虑症状可能会增加认知能力下降的风险。此外,它们表明,将抑郁和焦虑用作临床标志物可能有助于识别认知能力下降的最早迹象。